BMYMP vs LLY: Valuation Comparison 2026
Side-by-side fundamentals for Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) and Eli Lilly and Company (LLY) — market cap, PE, PEG and sector. All figures from SEC filings and market data.
| Metric | BMYMP | LLY |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Current Price | $400 | $1,122.5 |
| Market Cap | $814.59B | $1.06T |
| PE Ratio | 112.36 | 39.80 |
| PEG Ratio | — | 1.45 |
| PEG Verdict | N/A | Fairly Valued |